Status:
COMPLETED
Forecasts Impact of the Pre-therapeutic TEP-TDM in the 18-FDG Restaging of Upper Aero-digestive Tract Cancers
Lead Sponsor:
University Hospital, Brest
Conditions:
Cancer of Head and Neck
Eligibility:
All Genders
18+ years
Brief Summary
Head and neck (HN) cancer is the sixth most common malignancy worldwide, with around 800 000 new cases and 320 000 deaths in 2015. These malignancies encompass cancers of the oral cavity, oropharynx, ...
Eligibility Criteria
Inclusion
- biopsy proven HSNCC
- written consent
Exclusion
- previous head and neck malignancy
Key Trial Info
Start Date :
May 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
477 Patients enrolled
Trial Details
Trial ID
NCT03841175
Start Date
May 1 2018
End Date
August 1 2018
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609